Deborah Heyl‐Clegg
Deborah Heyl‐Clegg publishes mostly in Molecular Biology, Oncology and Psychiatry and Mental health, on topics such as Cancer, Stress, Anesthesia, and Immune Response, Pharmacological Receptor Mechanisms and Effects and Peptidase Inhibition and Analysis.
- World rank
- #5,379,357 of 7,710,434 ranked researchers
- Rank in United States
- #1,366,020 of 1,627,098
- Works
- 21
- Citations
- 3
- Citations per work
- 0.1
What does Deborah Heyl‐Clegg research?
Deborah Heyl‐Clegg's work is mostly in Biochemistry, Genetics and Molecular Biology (46%), Medicine (28%), Neuroscience (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1150.9%
- Health Sciences628.1%
- Medicine628.1%
- Everything else421.0%
- 1Molecular Biology42% of their works
- 2Oncology12% of their works
- 3Psychiatry and Mental health9% of their works
- 4Physiology7% of their works
- 5Cellular and Molecular Neuroscience5% of their works
- 6Cancer Research4% of their works
Research topics
- Cancer, Stress, Anesthesia, and Immune Response
- Pharmacological Receptor Mechanisms and Effects
- Peptidase Inhibition and Analysis
- Alzheimer's disease research and treatments
- Nicotinic Acetylcholine Receptors Study
- Neuropeptides and Animal Physiology
- Cancer, Hypoxia, and Metabolism
- Chemical Synthesis and Analysis
Which keywords describe Deborah Heyl‐Clegg's research?
The keywords of their largest research topics: Cancer Therapy, Tumor Microenvironment, Chronic Stress, Tumor Growth, Amyloid Hypothesis, Chaperone, Fibroblast Activation Protein and Immunosuppression.
- Warburg Effect
- HIF-1
- Receptors
- Neuropeptides
- Tau Pathology
- Immunosuppression
- Chaperone
- Tumor Growth
- Tumor Microenvironment
- Cancer Therapy
- Chronic Stress
- Amyloid Hypothesis
- Fibroblast Activation Protein
- Sigma-1 Receptor
- Crystal Structure
- Nicotinic Acetylcholine Receptors
- Drug Discovery
- Peptide Synthesis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Cancer Therapy82 topics
- Tumor Microenvironment62 topics
- Chronic Stress51 topic
- Tumor Growth51 topic
- Amyloid Hypothesis41 topic
- Chaperone41 topic
- Fibroblast Activation Protein41 topic
- Immunosuppression41 topic
- Sigma-1 Receptor41 topic
- Tau Pathology41 topic
- Crystal Structure31 topic
- Neuropeptides31 topic
- Nicotinic Acetylcholine Receptors31 topic
- Receptors31 topic
- Drug Discovery21 topic
- HIF-121 topic
- Peptide Synthesis21 topic
- Warburg Effect21 topic
Where does Deborah Heyl‐Clegg work?
Deborah Heyl‐Clegg's main affiliation in the publication record is Eastern Michigan University, United States.
How many publications and citations does Deborah Heyl‐Clegg have?
OpenAlex counts 21 works and 3 citations for Deborah Heyl‐Clegg, an h-index of 1, ranking #5,379,357 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Deborah Heyl‐Clegg. Posts are plain text and can be reported.